ISSN Online:2229-3566
ISSN Print: 2277-4343
Article: INVESTIGATIONAL CANCER DRUG INHIBITS THE EXTRACELLULAR SIGNAL REGULATED PROTEIN KINASES (ERK1): AN IN-SILICO APPROACH
Article Category: Pharmacy
DOI: 10.7897/2277-4343.06128
Pages: 138-143
Author: Hemalatha S*, Kiresee Saghana P.R, Anand Krishnamurthy
Abstract:
Keyword: Skin cancer, ERK1, Transcriptional factors AP-1 and NF-κB, Ingenol Mebutate, Methyl lestosterone, Ponatinib